Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA region

Under the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA markets and Sun Pharma will be responsible for product supply, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3d4BgAj
via IFTTT